Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases.
Amyotrophic lateral sclerosis
Dyspnea
Motor neuron disease
Patient-reported outcome measure
Respiratory function
Vital capacity
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
27
03
2020
accepted:
16
06
2020
revised:
10
06
2020
pubmed:
25
6
2020
medline:
22
6
2021
entrez:
25
6
2020
Statut:
ppublish
Résumé
Poor monitoring of respiratory function may lead to late initiation of non-invasive ventilation (NIV) in patients with motor neuron diseases (MND). Monitoring could be improved by remotely assessing hypoventilation symptoms between clinic visits. We aimed to determine which patient-reported hypoventilation symptoms are best for screening reduced respiratory function in patients with MND, and compared them to the respiratory domain of the amyotrophic lateral sclerosis functional rating scale (ALSFRS-R). This prospective multi-center study included 100 patients with MND, who were able to perform a supine vital capacity test. Reduced respiratory function was defined as a predicted supine vital capacity ≤ 80%. We developed a 14-item hypoventilation symptom questionnaire (HYSQ) based on guidelines, expert opinion and think-aloud interviews with patients. Symptoms of the HYSQ were related to dyspnea, sleep quality, sleepiness/fatigue and pneumonia. The diagnostic performances of these symptoms and the ALSFRS-R respiratory domain were determined from the receiver operating characteristic (ROC) curves, area under the curve (AUC), sensitivity, specificity, predictive values and accuracy. Dyspnea-related symptoms (dyspnea while eating/talking, while lying flat and during light activity) were combined into the MND Dyspnea Scale (MND-DS). ROC curves showed that the MND-DS had the best diagnostic performance, with the highest AUC = 0.72, sensitivity = 75% and accuracy = 71%. Sleep-quality symptoms, sleepiness/fatigue-related symptoms and the ALSFRS-R respiratory domain showed weak diagnostic performance. The diagnostic performance of the MND-DS was better than the respiratory domain of the ALSFRS-R for screening reduced respiratory function in patients with MND, and is, therefore, the preferred method for (remotely) monitoring respiratory function.
Sections du résumé
BACKGROUND
BACKGROUND
Poor monitoring of respiratory function may lead to late initiation of non-invasive ventilation (NIV) in patients with motor neuron diseases (MND). Monitoring could be improved by remotely assessing hypoventilation symptoms between clinic visits. We aimed to determine which patient-reported hypoventilation symptoms are best for screening reduced respiratory function in patients with MND, and compared them to the respiratory domain of the amyotrophic lateral sclerosis functional rating scale (ALSFRS-R).
METHODS
METHODS
This prospective multi-center study included 100 patients with MND, who were able to perform a supine vital capacity test. Reduced respiratory function was defined as a predicted supine vital capacity ≤ 80%. We developed a 14-item hypoventilation symptom questionnaire (HYSQ) based on guidelines, expert opinion and think-aloud interviews with patients. Symptoms of the HYSQ were related to dyspnea, sleep quality, sleepiness/fatigue and pneumonia. The diagnostic performances of these symptoms and the ALSFRS-R respiratory domain were determined from the receiver operating characteristic (ROC) curves, area under the curve (AUC), sensitivity, specificity, predictive values and accuracy.
RESULTS
RESULTS
Dyspnea-related symptoms (dyspnea while eating/talking, while lying flat and during light activity) were combined into the MND Dyspnea Scale (MND-DS). ROC curves showed that the MND-DS had the best diagnostic performance, with the highest AUC = 0.72, sensitivity = 75% and accuracy = 71%. Sleep-quality symptoms, sleepiness/fatigue-related symptoms and the ALSFRS-R respiratory domain showed weak diagnostic performance.
CONCLUSION
CONCLUSIONS
The diagnostic performance of the MND-DS was better than the respiratory domain of the ALSFRS-R for screening reduced respiratory function in patients with MND, and is, therefore, the preferred method for (remotely) monitoring respiratory function.
Identifiants
pubmed: 32577867
doi: 10.1007/s00415-020-10003-5
pii: 10.1007/s00415-020-10003-5
pmc: PMC7578163
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
3310-3318Subventions
Organisme : ALS Foundation Netherlands
ID : 2016-51
Références
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):377-81
pubmed: 22013242
Neurology. 2003 Jul 22;61(2):171-7
pubmed: 12874394
Neurology. 2016 Nov 1;87(18):1878-1883
pubmed: 27581221
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
Amyotroph Lateral Scler. 2010;11(1-2):194-202
pubmed: 19452343
Eur J Neurol. 2012 Mar;19(3):360-75
pubmed: 21914052
Muscle Nerve. 2006 Jan;33(1):127-32
pubmed: 16258948
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):120-3
pubmed: 25205208
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):348-355
pubmed: 30957547
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):86-91
pubmed: 27915482
Amyotroph Lateral Scler. 2008;9(1):59-62
pubmed: 17924236
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):331-341
pubmed: 29661084
Amyotroph Lateral Scler. 2006 Jun;7(2):80-5
pubmed: 16753971
Eur J Neurol. 2018 Mar;25(3):556-e33
pubmed: 29266547
Neurology. 2019 Jul 16;93(3):e306-e316
pubmed: 31182506
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):461-472
pubmed: 31204525
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):371-6
pubmed: 21849339
Ther Adv Neurol Disord. 2019 Jun 21;12:1756286419857040
pubmed: 31258624
J Neuromuscul Dis. 2018;5(4):431-438
pubmed: 30372689
Chest. 2002 Feb;121(2):436-42
pubmed: 11834654
Nat Sci Sleep. 2019 Aug 09;11:97-111
pubmed: 31496852
J Neurol. 2020 Jun;267(6):1615-1621
pubmed: 32052165
Neurology. 2009 Oct 13;73(15):1218-26
pubmed: 19822872
Respir Care. 2012 Sep;57(9):1425-30
pubmed: 22348449
Respir Med. 2019 Jul - Aug;154:116-121
pubmed: 31234039
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):46-52
pubmed: 27978772
J Neurol Sci. 2001 Oct 15;191(1-2):75-8
pubmed: 11676995
Can J Neurol Sci. 2010 Jan;37(1):54-60
pubmed: 20169774
J Neurol. 2020 Jun;267(6):1754-1759
pubmed: 32125520
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Dec;5(4):240-4
pubmed: 15799554
J Neurol Neurosurg Psychiatry. 2017 May;88(5):381-385
pubmed: 27888187